Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (161-170 of 400) with videos related to

Pageof 40
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
EJNMMI Physics|November 3, 2020
Performance evaluation of fifth-generation ultra-high-resolution SPECT system with two stationary detectors and multi-pinhole imagingJan V Hoffmann, Jan P Janssen, Takayuki Kanno, et al.
The Prostate|July 21, 2022
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapyPhilipp E Hartrampf, Franz-Xaver Weinzierl, Anna Katharina Seitz, et al.
Theranostics|January 19, 2018
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patientsConstantin Lapa, Malte Kircher, Heribert Hänscheid, et al.
Frontiers in Nuclear Medicine|April 27, 2026
Prognostic impact of discordant lesions on [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasmsTim Jedamzik, Aleksander Kosmala, Stefan Kircher, et al.
Scientific Reports|June 17, 2016
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experienceR A Werner, K Lückerath, J S Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2016
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodesChristina Bluemel, Gonca Safak, Andreas Cramer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2022
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinomaRudolf A Werner, Cyrus Sayehli, Heribert Hänscheid, et al.
Pageof 40

Showing results (161-170 of 400) with videos related to

Sort By:
Pageof 40
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
EJNMMI Physics|November 3, 2020
Performance evaluation of fifth-generation ultra-high-resolution SPECT system with two stationary detectors and multi-pinhole imagingJan V Hoffmann, Jan P Janssen, Takayuki Kanno, et al.
The Prostate|July 21, 2022
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapyPhilipp E Hartrampf, Franz-Xaver Weinzierl, Anna Katharina Seitz, et al.
Theranostics|January 19, 2018
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patientsConstantin Lapa, Malte Kircher, Heribert Hänscheid, et al.
Frontiers in Nuclear Medicine|April 27, 2026
Prognostic impact of discordant lesions on [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasmsTim Jedamzik, Aleksander Kosmala, Stefan Kircher, et al.
Scientific Reports|June 17, 2016
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experienceR A Werner, K Lückerath, J S Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2016
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodesChristina Bluemel, Gonca Safak, Andreas Cramer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2022
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinomaRudolf A Werner, Cyrus Sayehli, Heribert Hänscheid, et al.
Pageof 40